These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2695 related articles for article (PubMed ID: 7512644)

  • 61. Correlation between the lung distribution patterns of Lu-ECAM-1 and melanoma experimental metastases.
    Zhu D; Pauli BU
    Int J Cancer; 1993 Feb; 53(4):628-33. PubMed ID: 8436436
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protein kinases in normal and transformed melanocytes.
    Quong RY; Bickford ST; Ing YL; Terman B; Herlyn M; Lassam NJ
    Melanoma Res; 1994 Oct; 4(5):313-9. PubMed ID: 7858416
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Paclitaxel and water-soluble poly (L-glutamic acid)-paclitaxel, induce direct chromosomal abnormalities and cell death in a murine metastatic melanoma cell line.
    Multani AS; Li C; Ozen M; Yadav M; Yu DF; Wallace S; Pathak S
    Anticancer Res; 1997; 17(6D):4269-74. PubMed ID: 9494519
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PET in oncology: will it replace the other modalities?
    Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
    Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
    Bernhard H; Karbach J; Wölfel T; Busch P; Störkel S; Stöckle M; Wölfel C; Seliger B; Huber C; Meyer zum Büschenfelde KH
    Int J Cancer; 1994 Dec; 59(6):837-42. PubMed ID: 7989126
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differences in expression of metalloproteinases and plasminogen activators in murine melanocytes and B16 melanoma variants: lack of association with in vitro invasion.
    Huijzer JC; Uhlenkott CE; Meadows GG
    Int J Cancer; 1995 Sep; 63(1):92-9. PubMed ID: 7558459
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The invisible colours of melanoma. A telespectrophotometric diagnostic approach on pigmented skin lesions.
    Bono A; Tomatis S; Bartoli C; Cascinelli N; Clemente C; Cupeta C; Marchesini R
    Eur J Cancer; 1996 Apr; 32A(4):727-9. PubMed ID: 8695280
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plantar melanoma in black South Africans.
    Hudson DA; Krige JE
    Br J Surg; 1993 Aug; 80(8):992-4. PubMed ID: 8402099
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice.
    Ashizawa T; Okamoto A; Okabe M; Kobayashi S; Arai H; Saito H; Kasai M; Gomi K
    Anticancer Drugs; 1995 Dec; 6(6):763-70. PubMed ID: 8845489
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ocular melanoma: an experimental model in New Zealand white rabbits.
    Rodriguez Vicente J; Vicente Ortega V; Garcia Serrano F; Garcia Rojo B
    Melanoma Res; 1993 Jun; 3(3):195-202. PubMed ID: 8400856
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nonspecific cell-mediated cytotoxicity in the seawater teleosts (Sparus aurata and Dicentrarchus labrax): ultrastructural study of target cell death mechanisms.
    Meseguer J; Esteban MA; Mulero V
    Anat Rec; 1996 Apr; 244(4):499-505. PubMed ID: 8694285
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Establishment and characterization of human ocular melanoma cell lines.
    Aubert C; Rouge F; Reillaudou M; Metge P
    Int J Cancer; 1993 Jul; 54(5):784-92. PubMed ID: 8325707
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic evaluation of intracranial metastasis in malignant melanoma.
    Saha S; Meyer M; Krementz ET; Hoda S; Carter RD; Muchmore J; Sutherland C
    Ann Surg Oncol; 1994 Jan; 1(1):38-44. PubMed ID: 7834426
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.
    Smith KS; Folz BA; Adams EG; Bhuyan BK
    Cancer Chemother Pharmacol; 1995; 35(6):471-82. PubMed ID: 7533669
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of different image acquisition techniques for a computer vision system in the diagnosis of malignant melanoma.
    Schindewolf T; Schiffner R; Stolz W; Albert R; Abmayr W; Harms H
    J Am Acad Dermatol; 1994 Jul; 31(1):33-41. PubMed ID: 8021369
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Favourable melanoma prognosis associated with the expression of the tumour necrosis factor receptor and the alpha1beta1 integrin: a preliminary report.
    Gilhar A; Ullmann Y; Kalish RS; Berkutski T; Azizi E; Bank I
    Melanoma Res; 1997 Dec; 7(6):486-95. PubMed ID: 9464621
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Establishment and characterization of human vaginal malignant melanoma xenotransplants.
    Sawada M; Terada N; Nishizawa Y; Ito S; Wakamatsu K; Takemura K; Yamamoto T; Ozaki M; Sakamoto H; Tanizawa O
    Anticancer Res; 1994; 14(4A):1477-82. PubMed ID: 7526770
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of preoperative ultrasonography for patients with dense cataract: a retrospective study of 509 cases.
    Anteby II; Blumenthal EZ; Zamir E; Waindim P
    Ophthalmic Surg Lasers; 1998 Feb; 29(2):114-8. PubMed ID: 9507254
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study.
    Mordoh J; Kairiyama C; Bover L; Solarolo E
    Medicina (B Aires); 1997; 57(4):421-7. PubMed ID: 9674264
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structure of 5' region of human tenascin-R gene and characterization of its promoter.
    Gherzi R; Leprini A; Siri A; Zardi L
    DNA Cell Biol; 1998 Mar; 17(3):275-82. PubMed ID: 9539107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 135.